Make the profile of
Clinevo Technologies yours.

Company description

Clinevo Technologies develops cloud-based and on-premises software solutions for life sciences organizations, with a focus on drug safety, quality management, and clinical trials. Headquartered in Hicksville, New York, with a strategic presence across the USA, UK, Europe, and India, the company serves pharmaceutical, biotechnology, medical device, cosmetic, nutraceutical, veterinary, vaccine, and contract research organizations (CROs) globally.

Clinevo's platform is designed to address compliance, operational efficiency, and cost reduction across critical life sciences domains. The company holds ISO 9001 and ISO 27001 certifications and maintains compliance with USFDA, EMA, Health Canada, ICH, GxP, GAMP, HIPAA, GDPR, 21 CFR Part 11, and Annex 11 requirements. Solutions are available as both cloud-hosted and on-premises deployments, and the company offers 24/7 support alongside integration of Generative AI (GenAI) capabilities into its software offerings.

Core Solution Areas

• Pharmacovigilance Software Solutions: Supports comprehensive drug safety management, including case processing, signal detection, literature management, and regulatory reporting, with a focus on global regulatory compliance.
• Quality Assurance Software Solutions: Provides tools to help organizations maintain quality standards across their processes and operations.
• Clinical Trial Software Solutions: Simplifies complex clinical trial processes to support efficient and compliant research operations.
• Data Warehouse Software Solutions: Offers robust data warehouse development to help organizations consolidate and utilize their data effectively.

Key Capabilities and Platform Features

• End-to-End Integrated Platform: A single solution covering all clinical and safety processes in a seamless manner.
• Complete Automation and Digitization: Eliminates manual workflows to improve operational efficiency.
• Faster Deployment and Migration: Accelerates go-live timelines and simplifies migration from legacy systems.
• Cost and Efficiency Gains: Reported to reduce IT expenses by up to 50% while enhancing productivity.
• GenAI Integration: Incorporates Generative AI across solutions to address challenges such as manual case intake, literature surveillance, and pharmacovigilance automation.
• Regulatory Gateways: Supports multiple regulatory submission gateways for global reporting requirements.

Challenges Addressed

• System and vendor inconsistencies across life sciences operations
• Manual processes and integration difficulties
• Limited post-production support from existing vendors
• Complex data migration hurdles
• Need for swift system deployment
• Poor user experience in legacy platforms

Notable Details

• Certified ISO 9001 for quality management and ISO 27001 for information security
• Compliant with a broad range of international regulatory frameworks including USFDA, EMA, HIPAA, GDPR, 21 CFR Part 11, and Annex 11
• Offers both cloud and on-premises deployment options
• Provides 24/7 customer support
• Publishes regular content on pharmacovigilance topics including AI and automation in drug safety, literature management, and case intake operations

Clinevo positions itself as an end-to-end technology partner for life sciences companies seeking to consolidate their drug safety, quality, and clinical operations onto a validated, compliant, and integrated software platform.

AI-generated · replace with your own

Software attributed to Clinevo Technologies

• Clinevo OnePVView
• Clinevo SafetyView
• Clinevo Case IntakeView
• Clinevo Signal DetectionView
• Clinevo Literature AutomationView
• Clinevo SDEAView
• Clinevo OneClinicalTrial PlatformView
• eTMFView
• EDCView
• Clinevo eCOAView
• Clinevo eConsentView

Edit all with premium access